Filing Details

Accession Number:
0001209191-13-028140
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-22 17:49:06
Reporting Period:
2013-05-20
Filing Date:
2013-05-22
Accepted Time:
2013-05-22 17:49:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389072 Heartware International Inc. HTWR Surgical & Medical Instruments & Apparatus (3841) 980498958
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1404735 Newell Denis Wade C/O Heartware International, Inc.
205 Newbury Street, Suite 101
Framingham MA 01701
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-20 4,000 $99.00 4,966 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2013-05-21 1,000 $0.00 1,000 $95.05
Common Stock Restricted Stock Unit Acquisiton 2013-05-21 1,000 $0.00 1,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,000 2023-05-21 No 4 A Direct
2,250 2017-05-21 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,750 Direct
Footnotes
  1. Nickeli Holdings Pty. Limited as Trustee of the Wade Family Superannuation Fund.
  2. The stock options become exercisable in four equal installments on May 1, 2014, May 1, 2015, May 1, 2016 and May 1, 2017 subject to Dr. Wade's continuous service as a director of the Company through each date. In addition, the stock options will immediately vest upon the occurrence of a change in control (as defined in the 2012 Incentive Award Plan) or upon Dr. Wade's death prior to settlement.
  3. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  4. The restricted stock units become exercisable in four equal installments on May 1, 2014, May 1, 2015, May 1, 2016 and May 1, 2017 subject to Dr. Wade's continuous service as a director of the Company through each date. In addition, the restricted stock units will immediately vest upon the occurrence of a change in control (as defined in the 2012 Incentive Award Plan) or upon Dr. Wade's death prior to settlement.